Qiagen posts investor presentation outlining Q2 2026 results and growth strategy

QGEN•2026-08-07

Qiagen outlined 2028 targets of about 7% net sales CAGR at constant exchange rates, adjusted operating margin of at least 31%.
Strategy calls for at least USD 2 billion net sales at constant exchange rates from growth pillars by 2028.
Plan includes at least 250 bps adjusted operating margin expansion from 2024 to 2028, supported by efficiency and digitization.
Capital allocation framework targets at least USD 1 billion in shareholder returns from 2024 to 2028, excluding M&A.
2028 product targets include QIAcuity net sales of at least USD 250 million, QIAstat-Dx at least USD 200 million, both at constant exchange rates.

Sources

Docs